Our top pick for
Interface Inc is a furnishings, fixtures & appliances business based in the US. Interface shares (TILE) are listed on the NASDAQ and all prices are listed in US Dollars. Interface employs 3,742 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$15.12|
|52-week range||$5.90 - $17.10|
|50-day moving average||$14.85|
|200-day moving average||$14.46|
|Wall St. target price||$18.50|
|Dividend yield||$0.04 (0.26%)|
|Earnings per share (TTM)||$0.81|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||15.12|
|1 month (2021-09-22)||4.71%|
|3 months (2021-07-22)||7.16%|
|6 months (2021-04-22)||22.98%|
|1 year (2020-10-22)||139.24%|
|2 years (2019-10-22)||-1.69%|
|3 years (2018-10-22)||19.72|
|5 years (2016-10-21)||16.3|
Valuing Interface stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Interface's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Interface's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Interface shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Interface's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.59. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Interface's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Interface's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $148 million.
The EBITDA is a measure of a Interface's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||8.56%|
|Gross profit TTM||$409.4 million|
|Return on assets TTM||4.5%|
|Return on equity TTM||16.16%|
|Market capitalisation||$892.9 million|
TTM: trailing 12 months
There are currently 1.2 million Interface shares held short by investors – that's known as Interface's "short interest". This figure is 13.8% down from 1.3 million last month.
There are a few different ways that this level of interest in shorting Interface shares can be evaluated.
Interface's "short interest ratio" (SIR) is the quantity of Interface shares currently shorted divided by the average quantity of Interface shares traded daily (recently around 368714.92063492). Interface's SIR currently stands at 3.15. In other words for every 100,000 Interface shares traded daily on the market, roughly 3150 shares are currently held short.
However Interface's short interest can also be evaluated against the total number of Interface shares, or, against the total number of tradable Interface shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Interface's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Interface shares in existence, roughly 20 shares are currently held short) or 0.0202% of the tradable shares (for every 100,000 tradable Interface shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Interface.
Find out more about how you can short Interface stock.
Dividend payout ratio: 3.92% of net profits
Recently Interface has paid out, on average, around 3.92% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Interface shareholders could enjoy a 0.26% return on their shares, in the form of dividend payments. In Interface's case, that would currently equate to about $0.04 per share.
While Interface's payout ratio might seem low, this can signify that Interface is investing more in its future growth.
Interface's most recent dividend payout was on 16 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 1 September 2021 (the "ex-dividend date").
Interface's shares were split on a 2:1 basis on 15 June 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Interface shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Interface shares which in turn could have impacted Interface's share price.
Over the last 12 months, Interface's shares have ranged in value from as little as $5.9006 up to $17.0982. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Interface's is 1.9587. This would suggest that Interface's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Interface, Inc. , a modular flooring company, designs, produces, and sells modular carpet products primarily in the Americas, Europe, and the Asia-Pacific. The company offers modular carpets under the Interface and FLOR brand names; carpet tiles under the GlasBacRE name for use in commercial interiors, including offices, healthcare facilities, airports, educational and other institutions, hospitality spaces, and retail facilities, as well as residential interiors; modular resilient flooring products; rubber flooring under the norament and noraplan brand names; and luxury vinyl tile products. It also produces and sells an adapted version of its carpet tile for the healthcare facilities market; and two-meter roll goods that are structure-backed for use in education, healthcare, and government markets, as well as carpet replacement, installation, and maintenance services. In addition, the company sells and licenses a proprietary antimicrobial chemical compound under the Intersept name for use in interior finishes; sells TacTiles, a carpet tile installation system, as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. It sells its products directly to end-users, as well as indirectly through independent contractors or distributors, and FLOR line of products through Internet sales and commercial sales force. The company has product showrooms or design studios in the United States, Canada, Mexico, England, France, Germany, Spain, the Netherlands, India, Australia, Norway, the United Arab Emirates, Russia, Singapore, Hong Kong, Thailand, China, and others.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.